DCTH Live signaler | Maksimer profitt med Getagraph.com

KJøP 117194 min ago

@ $4.59

Utstedt: 13 feb 2024 @ 15:32

Avkastning: 21.13%

Forrige signal: feb 6 - 16:18

Forrige signal: Selg

Avkastning: -0.33 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe...

Stats
Dagens volum	76 804.00
Gjennomsnittsvolum	209 751
Markedsverdi	136.57M
EPS	$0 ( 2024-03-26 )
Neste inntjeningsdato	( $-0.430 ) 2024-05-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.890
ATR14	$0.0110 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-19	Aharon Gil	Buy	26 882	Common Shares
2024-03-19	Salamon Steven A J	Buy	26 882	Common Shares
2024-03-19	Rosalind Advisors, Inc.	Buy	619 946	Pre-funded Warrants
2024-03-18	Rook Martha S.	Buy	125 000	Employee Stock Option (Right to Buy)
2024-03-18	Rook Martha S.	Buy	0

INSIDER POWER
93.93
Last 96 transactions
Buy: 8 343 756 \| Sell: 533 108

Volum Korrelasjon

Lang: -0.04 (neutral)

Kort: -0.85 (strong negative)

Signal:(32.428) Neutral

Delcath Systems Inc Korrelasjon

10 Mest positive korrelasjoner
META	0.947
JBSS	0.939
MANH	0.938
DSGX	0.937
CIFR	0.933
INOD	0.932
NVCT	0.932
IOAC	0.932
ASO	0.932
LIBY	0.931

10 Mest negative korrelasjoner
NCBS	-0.944
TSHA	-0.922
BWB	-0.915
GSMG	-0.915
IPA	-0.911
ALRS	-0.903
HLIO	-0.902
COFS	-0.901
CYRN	-0.9
GXGX	-0.899

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Delcath Systems Inc Korrelasjon - Valuta/Råvare

0.50
( neutral )

0.31
( neutral )

0.00
( neutral )

-0.36
( neutral )

0.69
( moderate )

-0.71
( moderate negative )

Delcath Systems Inc Økonomi

Annual	2023
Omsetning:	$2.07M
Bruttogevinst:	$1.30M (63.05 %)
EPS:	$-2.94

FY	2023
Omsetning:	$2.07M
Bruttogevinst:	$1.30M (63.05 %)
EPS:	$-2.94

FY	2022
Omsetning:	$2.72M
Bruttogevinst:	$2.03M (74.77 %)
EPS:	$-4.42

FY	2021
Omsetning:	$3.56M
Bruttogevinst:	$2.88M (81.13 %)
EPS:	$-8.85

Financial Reports:

No articles found.

Delcath Systems Inc

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System for Melphalan trade name for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.